Share
In 2022, Congress scored a victory for the American people when it passed legislation allowing Medicare to negotiate directly with drug companies over the cost of some prescription drugs.
Share
A bipartisan 32-state coalition is requesting that the U.S Supreme Court review a decision limiting Oklahoma’s authority to regulate PBMs.
Share
A bipartisan coalition of 39 attorneys general is encouraging Congress to take decisive action to reform the way PBMs conduct business.
Share
The DRUG Act would disincentivize drug manufacturers and pharmacy benefit managers from raising drug prices for patients.
Share
Independent experts are concerned about the practice of using Pharmacy Benefit Managers (PBMs) with high prescription costs in the United States.
Share
The PROTECT 340B would block health insurers and pharmacy benefit managers from treating 340B pharmacies differently.
Share
Abigail Spanberger (D-VA-07) led the introduction of a bipartisan bill that would prohibit insurers and pharmacy benefit managers from hurting hospitals and clinics that participate in the federal 340B Drug Pricing Program.
Share
Abigail Spanberger (D-VA-07) and Jodey Arrington (R-TX-19) have introduced bipartisan legislation to tackle the prescription drug affordability crisis, hold pharmacy benefit managers accountable, and lower drug costs for American patients.
Share
The bill that put a $35 monthly cap on insulin and allowed Medicare to negotiate the prices of other drugs turned two on Friday.
Share
The U.S. Senate Committee on HELP announced Monday it will investigate the price of asthma inhalers made by four pharmaceutical companies.
Augusta Free Press LLC | Privacy Policy
